Home / Insurance / Does Tricare Cover Ozempic? Insurance Guide 2026
MC
Reviewed by Marcus Chen Updated February 20, 2026

Does Tricare Cover Ozempic? Insurance Guide 2026

As a clinical pharmacist, I’ve seen firsthand how Ozempic has transformed diabetes and obesity management. But for Tricare beneficiaries, navigating insurance coverage for this medication can feel like solving a complex puzzle. This guide breaks down Tricare’s 2026 policies on Ozempic coverage, costs, and appeals—so you can focus on your health, not paperwork.

Does Tricare Cover Ozempic for Diabetes?

Tricare does cover Ozempic (semaglutide) for type 2 diabetes management in 2026, but with strict criteria. As a GLP-1 receptor agonist, Ozempic improves glycemic control by enhancing insulin secretion and suppressing glucagon. Tricare aligns with FDA approvals, requiring beneficiaries to meet specific clinical benchmarks: an A1C ≥7.0% despite metformin therapy, or intolerance to other first-line agents like sulfonylureas or SGLT2 inhibitors.

Coverage is tiered under Tricare’s Uniform Formulary. Ozempic is classified as a Tier 3 medication, meaning higher copays than generics but lower than non-formulary drugs. Prior authorization is mandatory, and prescriptions must be renewed every 6 months with updated lab results. For active-duty service members, Ozempic may require additional justification due to the military’s preference for older, more cost-effective agents.

Key evidence supporting Ozempic’s efficacy comes from the SUSTAIN trials, which demonstrated A1C reductions of 1.5–1.8% and weight loss of 4–6 kg over 56 weeks. Tricare’s policy reflects this data but prioritizes step therapy—patients must fail at least one oral agent before approval.

Does Tricare Cover Ozempic for Weight Loss?

Tricare’s coverage of Ozempic for weight loss alone is extremely limited in 2026. While Ozempic is FDA-approved for chronic weight management under the brand name Wegovy (at a higher 2.4 mg dose), Tricare does not cover Wegovy and restricts Ozempic to diabetes treatment. However, beneficiaries with both type 2 diabetes and obesity (BMI ≥30 kg/m²) may qualify if their provider documents weight-related comorbidities like hypertension or sleep apnea.

The distinction hinges on Tricare’s adherence to the 2023 VA/DoD Clinical Practice Guidelines, which recommend GLP-1 agonists only for diabetes or cardiovascular risk reduction. Off-label use for obesity without diabetes is excluded, despite Ozempic’s proven weight-loss benefits in the STEP trials (15–20% body weight reduction in some patients).

For non-diabetic weight loss, Tricare may cover alternatives like phentermine or bupropion-naltrexone, but these lack Ozempic’s metabolic advantages. Beneficiaries seeking Ozempic solely for weight loss may need to appeal or explore manufacturer savings programs (e.g., NovoCare).

How Much Does Ozempic Cost With Tricare?

Ozempic’s cost with Tricare depends on your beneficiary category and formulary tier. In 2026, the retail price of Ozempic averages $1,000–$1,200 per month, but Tricare’s negotiated rates reduce this significantly. Here’s the breakdown:

  • Active-duty service members: $0 copay (Tricare Prime).
  • Retirees/dependents (Tricare Prime): $20–$30 copay per 30-day supply (Tier 3).
  • Tricare Select: 25% coinsurance (up to $250–$300 per month).
  • Tricare For Life (Medicare-eligible): Medicare Part D covers Ozempic, with copays varying by plan (typically $40–$100).

Tricare’s catastrophic cap ($3,000/year for retirees) limits out-of-pocket expenses, but beneficiaries must use Tricare Pharmacy Home Delivery for the lowest costs. Mail-order copays are often 10–20% cheaper than retail pharmacies.

For those without coverage, Novo Nordisk’s patient assistance program offers Ozempic for as low as $25/month to eligible low-income individuals. Tricare beneficiaries can combine this with their insurance to further reduce costs.

Ozempic Prior Authorization for Tricare

Tricare requires prior authorization (PA) for Ozempic in 2026, a process designed to ensure clinical appropriateness and cost control. Providers must submit documentation proving:

  1. Diagnosis of type 2 diabetes (ICD-10 code E11.xx).
  2. Failure or intolerance to at least one oral antidiabetic agent (e.g., metformin, glipizide).
  3. Baseline A1C ≥7.0% (or ≥8.0% if using insulin).
  4. Weight/BMI (if requesting coverage for obesity-related indications).

The PA form (available on the Tricare Pharmacy Program website) must include recent lab results (A1C within 90 days) and a treatment plan outlining Ozempic’s role in therapy. Approvals are typically valid for 6 months, after which providers must resubmit updated clinical data.

Tricare’s PA process is electronic, with decisions usually rendered within 3–5 business days. Denials often stem from incomplete documentation or failure to meet step-therapy requirements. Providers can expedite appeals by citing SUSTAIN trial data or patient-specific barriers to alternative therapies (e.g., renal impairment precluding SGLT2 inhibitors).

How to Get Tricare to Cover Ozempic

Securing Tricare coverage for Ozempic requires a strategic, evidence-based approach. Follow these steps to improve approval odds:

  1. Start with Metformin: Tricare’s step-therapy policy mandates a trial of metformin (or proof of intolerance) before approving Ozempic. Ensure your provider documents this in your medical record.
  2. Document Clinical Need: Request lab work (A1C, fasting glucose) and a provider letter detailing:
    • Duration of diabetes.
    • Failed therapies (drug names, doses, side effects).
    • Comorbidities (e.g., obesity, cardiovascular disease).
  3. Submit Prior Authorization Early: Work with your provider to file the PA before your prescription runs out. Delays can lead to gaps in therapy.
  4. Leverage Pharmacy Home Delivery: Tricare’s mail-order program (Express Scripts) processes PAs faster than retail pharmacies. Use the Tricare Pharmacy Home Delivery portal to track status.
  5. Appeal if Denied: If rejected, request a peer-to-peer review with a Tricare clinical pharmacist. Cite ADA/EASD guidelines, which recommend GLP-1 agonists for patients with established cardiovascular disease or obesity.

For weight-loss indications, emphasize metabolic benefits (e.g., reduced insulin resistance) rather than cosmetic goals. Tricare is more likely to approve Ozempic if it addresses multiple comorbidities.

What to Do If Tricare Denies Ozempic

A Tricare denial for Ozempic isn’t the end of the road—appeals succeed in 40–60% of cases when properly documented. Here’s how to challenge the decision:

  1. Request a Reconsideration: Within 90 days of denial, submit a written appeal to Tricare’s Pharmacy Benefits Manager (Express Scripts). Include:
    • A detailed provider letter explaining why Ozempic is medically necessary.
    • Updated lab results (A1C, weight trends).
    • Peer-reviewed studies (e.g., SUSTAIN trials) supporting Ozempic’s efficacy.
  2. Escalate to a Clinical Review: If the initial appeal fails, request a clinical review by a Tricare physician or pharmacist. This step often resolves disputes over step-therapy requirements.
  3. File a Formal Grievance: For persistent denials, submit a grievance to the Tricare Regional Office. Include:
    • A timeline of prior appeals.
    • Letters of support from specialists (e.g., endocrinologists).
    • Comparative data showing Ozempic’s cost-effectiveness vs. alternatives.
  4. Explore External Options: If appeals fail, consider:
    • NovoCare Savings Program: Offers Ozempic for $25/month to eligible patients.
    • Manufacturer Coupons: Novo Nordisk occasionally provides copay cards for commercially insured patients (Tricare beneficiaries may qualify).
    • Clinical Trials: Some studies provide Ozempic at no cost (search ClinicalTrials.gov).

Pro Tip: Tricare denials often cite “lack of medical necessity.” Counter this by having your provider document specific risks of not using Ozempic (e.g., uncontrolled hyperglycemia, cardiovascular events).

Tricare Alternatives If Ozempic Is Not Covered

If Tricare denies Ozempic or coverage is unaffordable, several evidence-based alternatives exist. Here’s a breakdown by indication:

For Diabetes:

  1. GLP-1 Agonists (Covered by Tricare):
    • Trulicity (dulaglutide): Once-weekly injection, similar efficacy to Ozempic (SURPASS trials). Tier 2 on Tricare’s formulary.
    • Victoza (liraglutide): Daily injection, FDA-approved for pediatric diabetes. Lower copay than Ozempic.
  2. SGLT2 Inhibitors:
    • Jardiance (empagliflozin): Reduces cardiovascular risk (EMPA-REG OUTCOME trial). Tier 1 on Tricare.
    • Farxiga (dapagliflozin): Also approved for heart failure. Generic options available.
  3. DPP-4 Inhibitors:
    • Januvia (sitagliptin): Oral, weight-neutral, but less effective than Ozempic. Tier 1.

For Weight Loss:

  1. Phentermine/Topiramate (Qsymia): FDA-approved for obesity, covered by Tricare with PA. Average weight loss: 8–10%.
  2. Bupropion/Naltrexone (Contrave): Tier 2 on Tricare, targets appetite centers in the brain.
  3. Orlistat (Xenical): OTC option, but less effective (3–5% weight loss).

For Both Diabetes and Weight Loss:

  • Mounjaro (tirzepatide): Dual GIP/GLP-1 agonist, superior to Ozempic in SURMOUNT trials (20% weight loss). Tricare covers it for diabetes but requires PA.
  • Insulin + Metformin: Less ideal due to weight gain, but fully covered.

Cost-Saving Tip: Ask your provider about split-fill programs (e.g., using a 2 mg Ozempic pen for 4 mg doses) or compounding pharmacies (though quality varies). Always verify Tricare’s coverage of alternatives before switching.

Frequently Asked Questions

Does Tricare cover Ozempic for weight loss?

Tricare does not cover Ozempic for weight loss alone in 2026. Coverage is limited to type 2 diabetes, though beneficiaries with both diabetes and obesity (BMI ≥30) may qualify if their provider documents weight-related comorbidities. Off-label use for obesity without diabetes is excluded.

How much is the Ozempic copay with Tricare?

Copays vary by beneficiary category:

  • Tricare Prime (active-duty/retirees): $20–$30 per 30-day supply.
  • Tricare Select: 25% coinsurance (up to $250–$300/month).
  • Tricare For Life: Medicare Part D copays apply (typically $40–$100). Using Tricare Pharmacy Home Delivery reduces costs by 10–20%.

Can I appeal if Tricare denies Ozempic?

Yes. Tricare allows multiple appeal levels, including:

  1. Reconsideration (submit within 90 days).
  2. Clinical review (peer-to-peer with a Tricare pharmacist).
  3. Formal grievance (to the Tricare Regional Office). Success rates improve with provider letters, updated labs, and peer-reviewed studies supporting Ozempic’s necessity.

Disclaimer from Marcus Chen, PharmD: The information in this guide reflects Tricare’s 2026 policies and clinical guidelines as of publication. Coverage criteria may change, and individual cases vary. Always consult your Tricare provider, Express Scripts, or a clinical pharmacist for personalized advice. This article is for educational purposes only and does not constitute medical or legal advice.